LSTA Latest Press Releases

-- November 9, 2026 --

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces MAR001 Reduces Triglycerides Without Worsening Glycemic Control in Phase 2b TYDAL-TIMI 78 Trial; Results Presented as AHA 2026 Late-Breaker and Published in The New England Journal of Medicine Globe Newswire 9:00 AM

-- November 5, 2026 --

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, to Participate in Upcoming November Investor Conferences Globe Newswire 8:30 AM

-- November 3, 2026 --

INVESTIGATION ALERT - The M&A Class Action Firm Is Investigating the Merger - LFCR, LSTA, FSHP and BWIN - IS IT A FAIR DEAL FOR YOU? PRNewswire 12:18 PM

-- October 14, 2026 --

Lisata Therapeutics Appoints Jeff Farrow to Board of Directors Globe Newswire 4:05 PM

-- October 8, 2026 --

Lisata Therapeutics Announces New Method of Use Patent Granted for Certepetide in the Treatment of Pancreatic Cancer and Other Solid Tumors Globe Newswire 8:00 AM

-- October 5, 2026 --

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces First Patient Dosed in Phase 2 Clinical Trial of MAR002, a Potential Best-in-disease Investigational Therapy for the Treatment of Acromegaly Globe Newswire 8:00 AM

-- October 4, 2026 --

Halper Sadeh LLC is Investigating Whether BWIN, LSTA, ACVA are Obtaining Fair Deals for their Shareholders Globe Newswire 11:42 AM

-- October 3, 2026 --

EQUITY ALERT - The M&A Class Action Firm Launches Inquiry -- LSTA, FSHP, BWIN, and ACVA PRNewswire 6:39 PM

-- September 24, 2026 --

Marea Therapeutics, a Subsidiary of Lisata Therapeutics, Announces Upcoming Late-Breaking Presentation of MAR001 Clinical Data at the American Heart Association Scientific Sessions 2026 Globe Newswire 8:00 AM

-- September 17, 2026 --

Lisata Therapeutics Announces Acquisition of Marea Therapeutics and $225 Million Concurrent Private Placement Globe Newswire 9:26 AM

-- August 4, 2026 --

Lisata Therapeutics Provides Update Following Termination of Merger Agreement Globe Newswire 7:00 AM

-- June 26, 2026 --

Johnson Fistel Investigates Lisata Therapeutics, Inc. (LSTA) After Disclosures Concerning Acquisition Financing Globe Newswire 11:08 AM

-- June 16, 2026 --

Are LSTA, MCHX, CZR Obtaining Fair Deals for their Shareholders? PRNewswire 9:01 AM

-- June 10, 2026 --

Lisata Therapeutics Announces Commencement of Tender Offer by Kuva Labs Inc. Globe Newswire 8:00 AM

Market Data Delayed 15 Minutes